Sanchez-Mut, Jose Vicente http://orcid.org/0000-0002-9292-8521
Glauser, Liliane
Monk, David
Gräff, Johannes
Funding for this research was provided by:
Stiftung Synapsis - Alzheimer Forschung Schweiz AFS (.)
Heidi Seiler-Stiftung foundation (.)
Béatrice Ederer-Weber Stiftung Foundation (.)
Floshield Foundation (.)
Alzheimer's Association (NIRG-15-363964)
Fondation Jérôme Lejeune (.)
Ministerio de Educación, Cultura y Deporte (BFU2014-53093, BFU2017-85571-R)
Article History
Received: 24 June 2019
Accepted: 15 January 2020
First Online: 3 February 2020
Ethics approval and consent to participate
: Postmortem tissues were obtained from the IDIBELL Biobank, which is part of the eBrainNet Europe Bank “Network of Excellence” funded by the European Commission in the 6th Framework Program “Life Science” (LSHM-CT-2004-503039). Informed consent was obtained from all participants. The collection of all samples conforms to the relevant regulations, ethical considerations, and legislation as defined by the European Union.
: Not applicable.
: JVS-M and JG hold a patent for the use of PM20D1 methylation and haplotype as biomarkers for Alzheimer’s disease (European patent no. 16180434.9). The other authors declare that they have no competing interests.